Inject Spółka z Ograniczoną Odpowiedzialnością (KRS 0000754089, NIP 5242875644) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. INJECT operates in: Activities of head offices (PKD 70.10.Z). Industry: Consulting and management. The company has been listed in the National Court Register since October 19, 2018. INJECT's most recently reported net revenue was 6.0 K PLN for 2020.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Inject
Identity
- Name
- Inject Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- October 19, 2018
- Registry status as of
- November 21, 2025
- Latest entry
- June 21, 2021
- Founding act
- 09.10.2018 R.
Articles of association history (1)
- October 9, 2018: 09.10.2018 R.
Activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. ODLEWNICZA, 7, 03-231, WARSZAWA, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- WARSZAWA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.2298, 21.0117approx.
Risk and payment profile - Inject
Credibility rating
66.2 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/8 yrs
Board changes
0
0/8 yrs
PKD changes
0
0/8 yrs
Name changes
0
0/8 yrs
Data from 8 years of registry activity.
Credibility history
Payment reliability score from 2019–2020
Current: C (66/100)
Trend: improving (+34.8 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2019–2020
Current: 1.7 K PLN
Safe: 779.52 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Inject
Founded
October 19, 2018
7 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
70.10.Z
Activities of head offices
Share capital
5.0 K PLN
100 shares total
Shareholders
4
shareholders
Board
4 people
Filed years
2 years
2019–2020 · profitable: 1/2
Registry entries
8
latest: June 21, 2021
Revenue
6.0 K PLN
2020
Net profit
3.7 K PLN
2020
Assets
9.0 K PLN
2020
Equity
5.5 K PLN
2020
Valuation
21.5 K PLN
Medium confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Inject.
No ratings
Related articles
News
Agora in 2026: return to dividend after 6 years (PLN 0.25), EBITDA PLN 148 m, PLN 200 m strategic target
Agora S.A. - Warsaw-based media holding (Gazeta Wyborcza, the Helios cinema chain, Radio TOK FM and Złote Przeboje, AMS outdoor, Yieldbird) - paid its first dividend in six years (PLN 0.25 per share, PLN 11.65 m). The 2026–2029 strategy targets a cumulative PLN 2.50 per share in dividends and lifts EBITDA from PLN 148 m to PLN 200 m.
News
Archicom: PLN 1.80 per share dividend recommendation after a record 2025 - 2,847 apartments sold, 3x the market growth
Wrocław-based Archicom S.A. (KRS 0000555355) closed 2025 with revenue of PLN 961.7 m (+30% YoY), standalone net profit of PLN 229.9 m and 2,847 apartments sold (+30% YoY versus market +9.3%). The board recommends a PLN 1.80 per share dividend (PLN 105.3 m); the final decision rests with the AGM (scheduled for July 2026). The 2026 target: 3,200-3,500 units plus a debut in the Tricity. The first full year under Echo Investment control (74.04%) after the 2023 integration.
